Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aethlon Medical

0.3288
-0.0302-8.41%
Volume:31.74K
Turnover:10.85K
Market Cap:6.79M
PE:-0.33
High:0.3579
Open:0.3544
Low:0.3254
Close:0.3590
Loading ...

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

PR Newswire
·
29 Jan

BRIEF-Aethlon Medical Granted 180-Day Extension To Regain Nasdaq Compliance

Reuters
·
08 Jan

Aethlon Medical Inc - Granted 180-Day Extension to Regain Nasdaq Compliance With Minimum Bid Price Requirement

THOMSON REUTERS
·
08 Jan

Aethlon Medical provides update on availability of Hemopurifier device

TIPRANKS
·
20 Dec 2024

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5n1 Bird Flu

THOMSON REUTERS
·
20 Dec 2024

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

PR Newswire
·
20 Dec 2024

Maxim Group Sticks to Their Hold Rating for Aethlon Medical (AEMD)

TIPRANKS
·
15 Nov 2024

Aethlon Medical Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Nov 2024

Aethlon’s Future at Risk: Financial Struggles, Stockholder Dilution, and Market Challenges Loom

TIPRANKS
·
15 Nov 2024

AEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment Measures

Zacks Small Cap Research
·
14 Nov 2024

Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ...

GuruFocus.com
·
14 Nov 2024

Aethlon Medical Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

Aethlon Medical Advances Oncology Trials and Global Expansion

TIPRANKS
·
14 Nov 2024

Aethlon Medical Q2 2025 GAAP EPS $(0.20), Inline

Benzinga
·
14 Nov 2024

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

THOMSON REUTERS
·
14 Nov 2024

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

PR Newswire
·
14 Nov 2024

Aethlon Medical Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

Aethlon Medical Enrolls First Patient in Hemopurifier Trial -- Shares Up 14% Pre-Bell

MT Newswires Live
·
11 Nov 2024

BRIEF-Aethlon Medical Reaches Key Milestone With Enrollment Of The First Patient In (FPI) Its Hemopurifier Cancer Trial In Australia

Reuters
·
11 Nov 2024

Aethlon Medical Reaches Key Milestone With Enrollment of the First Patient in (Fpi) Its Hemopurifier® Cancer Trial in Australia

THOMSON REUTERS
·
11 Nov 2024